INTERIM RESULTS OF A POST-AUTHORIZATION SAFETY STUDY (PASS) ON THE LONG-TERM SAFETY OF FACILITATED SCIG 10% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES IN THE US
2021 ◽
Vol 147
(2)
◽
pp. AB73
2012 ◽
Vol 18
(9)
◽
pp. 1438-1445
◽
2015 ◽
Vol 135
(1)
◽
pp. 273-275
◽
1982 ◽
Vol 2
(S2)
◽
pp. 15S-21S
◽
2016 ◽
Vol 137
(2)
◽
pp. AB179
2019 ◽
Vol 143
(2)
◽
pp. AB117
2000 ◽
Vol 12
(6)
◽
pp. 0267-0270
◽